Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The levodopa test in Parkinson's disease

D F D'Costa1, L J Sheehan, P A Phillips

  • 1Department of Geriatic Medicine, Ipswich General Hospital, Suffolk.

Age and Ageing
|May 1, 1995
PubMed
Summary

A levodopa challenge test accurately predicts Parkinson's disease treatment response. This diagnostic tool helps confirm Parkinson's disease and identify alternative parkinsonian syndromes, improving clinical diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth.

Biomaterials·2022
Same author

Transmission of Xylella fastidiosa, Causal Agent of Citrus Variegated Chlorosis, by the Glassy-Winged Sharpshooter, Homalodisca coagulata.

Plant disease·2019
Same author

Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.

Neoplasia (New York, N.Y.)·2016
Same author

Fruit-derived phenolic compounds and pancreatic cancer: perspectives from Australian native fruits.

Journal of ethnopharmacology·2014
Same author

Disruption of foraging by argentine ants,Iridomyrmex humilis (mayr) (hymenoptera: Formicidae), in citrus trees through the use of semiochemicals and related chemicals.

Journal of chemical ecology·2013
Same author

RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.

Oncogene·2013

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Clinical diagnosis of Parkinson's disease can be challenging, especially in elderly patients presenting with symptoms like rigidity, bradykinesia, and tremor.
  • Differentiating Parkinson's disease from other parkinsonian syndromes is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the predictive value of a single levodopa challenge test for dopa responsiveness in newly diagnosed Parkinson's disease patients.
  • To assess the utility of the levodopa challenge test in confirming Parkinson's disease diagnosis and identifying alternative conditions.

Main Methods:

  • A cohort of 27 newly diagnosed patients with suspected Parkinson's disease was enrolled.
  • A single levodopa challenge test was administered to assess immediate response.
  • Patient outcomes and treatment response were evaluated at one month.

Main Results:

  • Out of 22 patients who completed the study, 17 (77%) showed a positive response to the levodopa challenge.
  • At one month, 18 patients (82%) demonstrated clinical improvement with dopa treatment.
  • The levodopa challenge test accurately predicted treatment response in 95% of patients, with only one false negative.

Conclusions:

  • A positive levodopa challenge test is a reliable indicator for confirming Parkinson's disease diagnosis.
  • A negative levodopa challenge test suggests alternative parkinsonian syndromes, prompting further diagnostic investigation.
  • The levodopa challenge test enhances diagnostic accuracy and aids in differentiating Parkinson's disease from other neurological disorders.

Related Experiment Videos